Literature DB >> 23046022

Surgical treatment of primary melanoma.

Antoni Bennàssar1, Priscila Ishioka, Antoni Vilalta.   

Abstract

The incidence of primary cutaneous malignant melanoma (MM) has been rapidly growing during the last decades with only a small rise in overall mortality. MM accounts for most of the deaths from skin malignancies due to its metastatic potential. However, early detection and wide surgical excision with histologically negative margins are nearly always curative for patients without micrometastatic disease. Although nonsurgical treatments have been increasingly used in recent years, surgery with standardized margins remains the only curative treatment modality for primary cutaneous MM. There are some special locations (e.g., the ear, nose, eyelid, genitalia, hand, or foot) where standardized wide surgery can not be completely achieved either for lack of tissue, ill-defined lesions, or cosmetic and functional reasons. Thus, skin surgeons dealing with these MMs should be well versed in new technologies such as confocal microscopy for the presurgical assessment of ill-defined lesions or the promising electrochemotherapy for nonsurgical tumors. Furthermore, a multidisciplinary melanoma team and a well-trained and experienced surgeon are mandatory to deal with these "out-of-the-guidelines" melanomas.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23046022     DOI: 10.1111/j.1529-8019.2012.01537.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  1 in total

1.  Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis.

Authors:  S Morteza Seyed Jafari; Christina Wiedmer; Simone Cazzaniga; Živa Frangež; Maziar Shafighi; Helmut Beltraminelli; Benedikt Weber; Hans-Uwe Simon; Robert E Hunger
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.